A biotechnology company developing therapeutic antibodies for Covid-19 infections is raising $483 million in its initial public offering of common stock. . . . → Read More: Covid-19 Antibody Developer Raises $483M in IPO
|
|||||
|
       
  |
 One comment - (Comments are closed)  Finance  biomedical, biotechnology, Canada, clinical trials, Covid-19, equity, FDA, investment, IPO, NIH, pharmaceuticals 
A Canadian medical school lab is helping evaluate and develop a pain relief drug made by a company developing therapies from cannabis. . . . → Read More: Industry, Univ Labs Partner on Cannabinoid Pain Drug Comments are closed Joint ventures/collaborations, New products biomedical, Canada, chemistry, Israel, life sciences, pharmaceuticals, physical sciences, preclinical, university 
An international research team identified key features of the complex wheat genome, including genes affecting the grain’s yield, quality, and survival. . . . → Read More: Wheat Genome Study IDs Critical Genes, Traits Comments are closed Joint ventures/collaborations, New products agriculture, Canada, economics, genomics, life sciences, university 
Drug maker Eli Lilly and National Institutes of Health are stopping a clinical trial testing a synthetic antibody to treat hospitalized Covid-19 patients. . . . → Read More: Lilly, NIH Halt Covid-19 Antibody Therapy Trial 2 comments - (Comments are closed) New products, Regulations biomedical, biotechnology, Canada, clinical trials, Covid-19, life sciences, NIH, pharmaceuticals 
A start-up company is using artificial intelligence to discover drugs that address the tumor stroma, a cellular network supporting cancerous tumors. . . . → Read More: New Company IDs Drugs Targeting Cancer Cell Networks One comment - (Comments are closed) Finance biomedical, biotechnology, Canada, cancer, engineering, entrepreneurs, equity, genomics, investment, life sciences, mathematics, pharmaceuticals, physical sciences, venture capital 
Six clinical testing laboratories worldwide plan to evaluate vaccines for protecting against Covid-19 infections with a common set of test protocols. . . . → Read More: Int’l Lab Network to Assess Covid-19 Vaccines One comment - (Comments are closed) New products, Regulations Asia, biomedical, Canada, clinical trials, Covid-19, Europe, life sciences, pharmaceuticals, standard 
A consortium of academic and industry labs is integrating electronic sensors and neural stimulation therapies into an early treatment protocol for spinal cord injuries. . . . → Read More: Group Advancing Electronic Spinal Cord Injury Therapies One comment - (Comments are closed) Finance, Joint ventures/collaborations biomedical, Canada, contract, DoD, engineering, life sciences, medical device, pharmaceuticals, physical sciences, semiconductors, stem cells, university 
First results from a clinical trial testing an experimental synthetic antibody, show patients receiving the therapy at a specific dosage, cleared their SARS-CoV-2 viruses within 11 days. . . . → Read More: Early Trial Results Show Antibody Treating Covid-19 2 comments - (Comments are closed) New products biomedical, biotechnology, Canada, clinical trials, Covid-19, life sciences, pharmaceuticals 
The European Commission announced today a contribution of €400 million ($US 477 million) to the COVID-19 Vaccine Global Access, or Covax, consortium. . . . → Read More: Covid-19 Vaccines, Therapies – 31 August 2020 2 comments - (Comments are closed) New products biomedical, Canada, clinical trials, Covid-19, engineering, life sciences, pharmaceuticals, software 
The number of new Covid-19 therapies increased by eight over the past week to 364, while the number of therapies in clinical trials also jumped by eight. . . . → Read More: Covid-19 Vaccines, Therapies – 17 August 2020 2 comments - (Comments are closed) New products biomedical, Canada, clinical trials, Covid-19, engineering, life sciences, pharmaceuticals, software |
||||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||